The p53–Fas–FasL tumor intrinsic pathway, thus, may only play a role for 5-FU chemotherapy efficacy in killing tumor cells through the Fas-mediated apoptosis, in a small portion of colorectal cancer patients. The gene discussed is FAS; the disease is neoplasm.